Related references
Note: Only part of the references are listed.Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Petra Kleiblova et al.
JOURNAL OF CELL BIOLOGY (2013)
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
Elise Ruark et al.
NATURE (2013)
Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis
Xavier Le Guezennec et al.
CELL METABOLISM (2012)
MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis
Yan Li et al.
HUMAN CELL (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers
Sarai Palanca Suela et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Rachael Natrajan et al.
CLINICAL CANCER RESEARCH (2009)
PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
David S. P. Tan et al.
CLINICAL CANCER RESEARCH (2009)
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
Robert C. Castellino et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop
Xiongbin Lu et al.
CANCER CELL (2007)
Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine
Oleg N. Demidov et al.
CELL STEM CELL (2007)
Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome
Panayiotis Loukopoulos et al.
CANCER SCIENCE (2007)
Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase
Sathyavageeswaran Shreeram et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Wip1 phosphatase modulates ATM-dependent signaling pathways
Sathyavageeswaran Shreeram et al.
MOLECULAR CELL (2006)
Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1
Akinori Yoda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice
Bonnie Nannenga et al.
MOLECULAR CARCINOGENESIS (2006)
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
H. Fujimoto et al.
CELL DEATH AND DIFFERENTIATION (2006)
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
XB Lu et al.
GENES & DEVELOPMENT (2005)
Substrate specificity of the human protein phosphatase 2Cδ Wip1
H Yamaguchi et al.
BIOCHEMISTRY (2005)
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway
DV Bulavin et al.
NATURE GENETICS (2004)
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
DV Bulavin et al.
NATURE GENETICS (2002)
Single nucleotide polymorphisms and the future of genetic epidemiology
NJ Schork et al.
CLINICAL GENETICS (2000)
Ataxia-telangiectasia: Phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity
SG Becker-Catania et al.
MOLECULAR GENETICS AND METABOLISM (2000)
Share Paper
